A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )
Status:
Unknown status
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
This is a Phase II , Open-label , Investigator-initiated Trail of Sequential GEMOX/NS
Chemotherapy in Patients With untreated Pancreatic cancer.
This study aims to evaluate the safety and efficacy of Sequential GEMOX/NS Chemotherapy as a
first-line treatment of untreated Pancreatic cancer.